Advanced Pharmacology for Care of the Family Week 4
NR566 Midterm Exam Review Question and correct
answers 100 %pass Quaranteed 2025-2026 /NR 566 ADV
PHARMACOLOGY WEEK 4 MIDTERM EXAM/Nr 566
Advanced pharmacology for care of the family
Chamberlain University.
Note: This is an original practice exam created for study purposes. Content is based on
the NR566 course curriculum covering Weeks 1–4 (pharmacokinetics,
pharmacodynamics, anti-infectives, cardiovascular, endocrine, and related topics).
Explanations appear in italics.
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
1. Which process describes what the body does to a drug, including absorption,
distribution, metabolism, and excretion?
A) Pharmacodynamics
B) Pharmacogenetics
C) Pharmacokinetics
D) Pharmacotherapeutics
Answer: C
Pharmacokinetics (PK) refers to the movement of a drug through the body—what the
body does to the drug. Pharmacodynamics describes what the drug does to the body.
,2. A patient with a low serum albumin level is prescribed a highly protein-bound
drug. What is the main concern?
A) Rapid renal excretion
B) Decreased therapeutic effect
C) Increased risk of drug toxicity
D) Reduced drug absorption
Answer: C
Low albumin means fewer binding sites, leading to more free (active) drug in the
bloodstream, which increases the risk of toxicity.
3. Which enzyme system in the liver is most commonly responsible for the
metabolism of the majority of drugs?
A) MAO system
B) Cholinesterase system
C) Glucuronidation system
D) Cytochrome P450 system
Answer: D
The Cytochrome P450 (CYP450) enzyme system is the primary pathway for hepatic drug
metabolism.
4. What is the primary site of drug excretion in the human body?
A) Kidneys
B) Liver
C) Lungs
D) Skin
Answer: A
While some drugs are excreted via bile or sweat, the kidneys are the main organ
responsible for drug excretion.
,5. Which of the following describes the "First-Pass Effect"?
A) Rapid renal clearance of a drug after the first dose
B) The binding of a drug to plasma proteins
C) Metabolism of an oral drug in the liver before reaching systemic circulation
D) The time it takes for a drug to reach steady state
Answer: C
Oral drugs are absorbed in the GI tract and pass through the liver via the portal vein,
where they may be significantly metabolized before entering systemic circulation.
6. How many half-lives does it typically take for a drug to reach steady-state
concentration?
A) 1 to 2
B) 2 to 3
C) 4 to 5
D) 7 to 10
Answer: C
It generally takes 4 to 5 half-lives for a drug to reach a plateau or steady-state
concentration in the plasma.
7. A medication with a narrow therapeutic index requires particular attention to
which principle?
A) Minimal monitoring is necessary
B) Small changes in concentration may cause toxicity or treatment failure
C) The medication can be given at any dose
D) Therapeutic drug monitoring is never useful
Answer: B
Narrow therapeutic index means the effective concentration is relatively close to the toxic
, concentration. Drugs in this category may require serum-level monitoring, careful dose
adjustment, and assessment for drug interactions.
8. Which organ is primarily responsible for metabolism of many medications?
A) Liver
B) Spleen
C) Pancreas
D) Kidneys
Answer: A
The liver contains numerous metabolic enzymes, including cytochrome P450 enzymes,
that transform many medications into metabolites.
9. What is the principal purpose of a loading dose?
A) To permanently increase renal clearance
B) To rapidly achieve a desired therapeutic concentration
C) To eliminate adverse effects
D) To prevent absorption
Answer: B
A loading dose is used when rapid achievement of therapeutic drug concentrations is
clinically desirable. The appropriate loading dose depends substantially on the
medication's volume of distribution and the target concentration.
10. Which statement best describes pharmacodynamics?
A) What the body does to the drug
B) How the drug is absorbed
C) What the drug does to the body
D) How the kidney eliminates the drug
NR566 Midterm Exam Review Question and correct
answers 100 %pass Quaranteed 2025-2026 /NR 566 ADV
PHARMACOLOGY WEEK 4 MIDTERM EXAM/Nr 566
Advanced pharmacology for care of the family
Chamberlain University.
Note: This is an original practice exam created for study purposes. Content is based on
the NR566 course curriculum covering Weeks 1–4 (pharmacokinetics,
pharmacodynamics, anti-infectives, cardiovascular, endocrine, and related topics).
Explanations appear in italics.
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
1. Which process describes what the body does to a drug, including absorption,
distribution, metabolism, and excretion?
A) Pharmacodynamics
B) Pharmacogenetics
C) Pharmacokinetics
D) Pharmacotherapeutics
Answer: C
Pharmacokinetics (PK) refers to the movement of a drug through the body—what the
body does to the drug. Pharmacodynamics describes what the drug does to the body.
,2. A patient with a low serum albumin level is prescribed a highly protein-bound
drug. What is the main concern?
A) Rapid renal excretion
B) Decreased therapeutic effect
C) Increased risk of drug toxicity
D) Reduced drug absorption
Answer: C
Low albumin means fewer binding sites, leading to more free (active) drug in the
bloodstream, which increases the risk of toxicity.
3. Which enzyme system in the liver is most commonly responsible for the
metabolism of the majority of drugs?
A) MAO system
B) Cholinesterase system
C) Glucuronidation system
D) Cytochrome P450 system
Answer: D
The Cytochrome P450 (CYP450) enzyme system is the primary pathway for hepatic drug
metabolism.
4. What is the primary site of drug excretion in the human body?
A) Kidneys
B) Liver
C) Lungs
D) Skin
Answer: A
While some drugs are excreted via bile or sweat, the kidneys are the main organ
responsible for drug excretion.
,5. Which of the following describes the "First-Pass Effect"?
A) Rapid renal clearance of a drug after the first dose
B) The binding of a drug to plasma proteins
C) Metabolism of an oral drug in the liver before reaching systemic circulation
D) The time it takes for a drug to reach steady state
Answer: C
Oral drugs are absorbed in the GI tract and pass through the liver via the portal vein,
where they may be significantly metabolized before entering systemic circulation.
6. How many half-lives does it typically take for a drug to reach steady-state
concentration?
A) 1 to 2
B) 2 to 3
C) 4 to 5
D) 7 to 10
Answer: C
It generally takes 4 to 5 half-lives for a drug to reach a plateau or steady-state
concentration in the plasma.
7. A medication with a narrow therapeutic index requires particular attention to
which principle?
A) Minimal monitoring is necessary
B) Small changes in concentration may cause toxicity or treatment failure
C) The medication can be given at any dose
D) Therapeutic drug monitoring is never useful
Answer: B
Narrow therapeutic index means the effective concentration is relatively close to the toxic
, concentration. Drugs in this category may require serum-level monitoring, careful dose
adjustment, and assessment for drug interactions.
8. Which organ is primarily responsible for metabolism of many medications?
A) Liver
B) Spleen
C) Pancreas
D) Kidneys
Answer: A
The liver contains numerous metabolic enzymes, including cytochrome P450 enzymes,
that transform many medications into metabolites.
9. What is the principal purpose of a loading dose?
A) To permanently increase renal clearance
B) To rapidly achieve a desired therapeutic concentration
C) To eliminate adverse effects
D) To prevent absorption
Answer: B
A loading dose is used when rapid achievement of therapeutic drug concentrations is
clinically desirable. The appropriate loading dose depends substantially on the
medication's volume of distribution and the target concentration.
10. Which statement best describes pharmacodynamics?
A) What the body does to the drug
B) How the drug is absorbed
C) What the drug does to the body
D) How the kidney eliminates the drug
